AAAAAA
Results: 1-25/77
Authors:
GAEDIGK A
TYNDALE RF
JURIMAROMET M
SELLERS EM
GRANT DM
LEEDER JM
Citation: A. Gaedigk et al., NAD(P)H-QUINONE OXIDOREDUCTASE - POLYMORPHISMS AND ALLELE FREQUENCIESIN CAUCASIAN, CHINESE AND CANADIAN NATIVE INDIAN AND INUIT POPULATIONS, Pharmacogenetics, 8(4), 1998, pp. 305-313
Authors:
DROLL K
BRUCEMENSAH K
OTTON SV
GAEDIGK A
SELLERS EM
TYNDALE RF
Citation: K. Droll et al., COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS, Pharmacogenetics, 8(4), 1998, pp. 325-333
Authors:
ZAWERTAILO LA
KAPLAN HL
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: La. Zawertailo et al., PSYCHOTROPIC EFFECTS OF DEXTROMETHORPHAN ARE ALTERED BY THE CYP2D6 POLYMORPHISM - A PILOT-STUDY, Journal of clinical psychopharmacology, 18(4), 1998, pp. 332-337
Authors:
OZDEMIR V
NARANJO CA
SHULMAN RW
HERRMANN N
SELLERS EM
REED K
KALOW W
Citation: V. Ozdemir et al., DETERMINANTS OF INTERINDIVIDUAL VARIABILITY AND EXTENT OF CYP2D6 AND CYP1A2 INHIBITION BY PAROXETINE AND FLUVOXAMINE IN-VIVO, Journal of clinical psychopharmacology, 18(3), 1998, pp. 198-207
Authors:
ROMACH MK
KAPLAN HL
BUSTO UE
SOMER G
SELLERS EM
Citation: Mk. Romach et al., A CONTROLLED TRIAL OF ONDANSETRON, A 5-HT3 ANTAGONIST, IN BENZODIAZEPINE DISCONTINUATION, Journal of clinical psychopharmacology, 18(2), 1998, pp. 121-131
Authors:
OZDEMIR V
NARANJO CA
HERRMANN N
SHULMAN RW
SELLERS EM
REED K
KALOW W
Citation: V. Ozdemir et al., THE EXTENT AND DETERMINANTS OF CHANGES IN CYP2D6 AND CYP1A2 ACTIVITIES WITH THERAPEUTIC DOSES OF SERTRALINE, Journal of clinical psychopharmacology, 18(1), 1998, pp. 55-61
Authors:
BUCZEK Y
LE AD
SELLERS EM
TOMKINS DM
Citation: Y. Buczek et al., EFFECT OF PENTYLENETETRAZOLE ON ETHANOL INTAKE, ETHANOL KINETICS, ANDSOCIAL-BEHAVIOR IN MALE WISTAR RATS, Alcoholism, clinical and experimental research, 22(2), 1998, pp. 428-436
Authors:
SELLERS EM
Citation: Em. Sellers, PHARMACOGENETICS AND ETHNORACIAL DIFFERENCES IN SMOKING, JAMA, the journal of the American Medical Association, 280(2), 1998, pp. 179-180
Authors:
SELLERS EM
TOMKINS DM
LE AD
ROMACH MK
Citation: Em. Sellers et al., INTERACTION OF SEROTONIN WITH OTHER NEUROTRANSMITTERS - IMPLICATIONS FOR TREATMENT, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 131-131
Authors:
PIANEZZA ML
SELLERS EM
TYNDALE RF
Citation: Ml. Pianezza et al., NICOTINE METABOLISM DEFECT REDUCES SMOKING, Nature, 393(6687), 1998, pp. 750-750
Authors:
NOWAK MP
SELLERS EM
TYNDALE RF
Citation: Mp. Nowak et al., CANADIAN NATIVE INDIANS EXHIBIT UNIQUE CYP2A6 AND CYP2C19 MUTANT ALLELE FREQUENCIES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 378-383
Authors:
PIANEZZA ML
SELLERS EM
TYNDALE RF
Citation: Ml. Pianezza et al., GENETICALLY VARIABLE CYP2A6 INFLUENCES SMOKING-BEHAVIOR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 1-1
Authors:
ZEMAN MV
PIANEZZA ML
LI NY
TYNDALE RF
SELLERS EM
Citation: Mv. Zeman et al., CHARACTERIZATION OF CYP2A6 ACTIVITY USING PLASMA COUMARIN MEASUREMENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 32-32
Authors:
ZAWERTAILO LA
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: La. Zawertailo et al., DEXTROMETHORPHANS ACTIVE METABOLITE CONTRIBUTES TO ITS ABUSE LIABILITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 39-39
Authors:
KILICARSLAN T
LI NY
BUSTO U
TYNDALE RF
SELLERS EM
Citation: T. Kilicarslan et al., FLUNITRAZEPAM - POLYMORPHIC METABOLISM BY CYP2C19, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 44-44
Authors:
BUSTO UE
SELLERS EM
KAPLAN HL
WRIGHT CE
GREENBLATT DJ
Citation: Ue. Busto et al., PHARMACOKINETIC PHARMACODYNAMIC EVALUATION OF ALPRAZOLAM SUSTAINED-RELEASE, BROMAZEPAM (B) AND LORAZEPAM (L)/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 113-113
Authors:
SELLERS EM
BUSTO UE
KAPLAN HL
SOMER G
BAYLON GJ
Citation: Em. Sellers et al., COMPARATIVE ABUSE LIABILITY OF CODEINE AND NARATRIPTAN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 121-121
Authors:
GAEDIGK A
TYNDALE RF
JURIMAROMET M
SELLERS EM
LEEDER JS
Citation: A. Gaedigk et al., GENETIC POLYMORPHISMS IN THE NAD(P)H - QUINONE OXIDOREDUCTASE (NQO1) GENE LOCUS, Clinical pharmacology and therapeutics, 63(2), 1998, p.
Authors:
CHEUNG S
NOLTE H
OTTON SV
TYNDALE RF
WU PH
SELLERS EM
Citation: S. Cheung et al., SIMULTANEOUS GAS-CHROMATOGRAPHIC DETERMINATION OF METHAMPHETAMINE, AMPHETAMINE AND THEIR P-HYDROXYLATED METABOLITES IN PLASMA AND URINE, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 77-87
Authors:
TYNDALE RF
DROLL KP
SELLERS EM
Citation: Rf. Tyndale et al., GENETICALLY DEFICIENT CYP2D6 METABOLISM PROVIDES PROTECTION AGAINST ORAL OPIATE DEPENDENCE, Pharmacogenetics, 7(5), 1997, pp. 375-379
Authors:
NOWAK MP
TYNDALE RF
SELLERS EM
Citation: Mp. Nowak et al., CYP2D6 PHENOTYPE AND GENOTYPE IN A CANADIAN NATIVE INDIAN POPULATION, Pharmacogenetics, 7(2), 1997, pp. 145-148
Authors:
NOWAK MP
TYNDALE RF
SELLERS EM
Citation: Mp. Nowak et al., CYP2D6 PHENOTYPE AND GENOTYPE IN A CANADIAN NATIVE INDIAN POPULATION, Pharmacogenetics, 7(2), 1997, pp. 145-148
Authors:
CHOW BLC
SELLERS EM
TOMKINS DM
Citation: Blc. Chow et al., EFFECT OF NALTREXONE AND ITS DERIVATIVES, NALMEFENE AND NALTRINDOLE, ON CONDITIONED ANTICIPATORY BEHAVIOR AND SACCHARIN INTAKE IN RATS, Behavioural pharmacology, 8(8), 1997, pp. 725-735
Authors:
TOMKINS DM
OTTON SV
JOHARCHI N
BERNS T
WU D
CORRIGALL WA
SELLERS EM
Citation: Dm. Tomkins et al., EFFECT OF CYP2D1 INHIBITION ON THE BEHAVIORAL-EFFECTS OF D-AMPHETAMINE, Behavioural pharmacology, 8(2-3), 1997, pp. 223-235
Authors:
LI Y
LI NY
SELLERS EM
Citation: Y. Li et al., COMPARISON OF CYP2A6 CATALYTIC ACTIVITY ON COUMARIN 7-HYDROXYLATION IN HUMAN AND MONKEY LIVER-MICROSOMES, European journal of drug metabolism and pharmacokinetics, 22(4), 1997, pp. 295-304